CompletedNCT05878327
Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With Thrombophilia
Studying Livedoid vasculopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Zurich
- Principal Investigator
- Juerg Hafner, Prof, MD, M.DUniversity Hospital Zurich, Dept. of Dermatology
- Intervention
- Thrombophilia screening(other)
- Enrollment
- 15 enrolled
- Eligibility
- 10-85 years · All sexes
- Timeline
- 2013 – 2015
Study locations (3)
- University hospital of Basel, Basel, Switzerland
- University hospital of Bern, Bern, Switzerland
- University hospital Zurich, Zurich, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05878327 on ClinicalTrials.gov